{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:33:35Z","timestamp":1794983615381,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-022-00859-0","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T07:03:20Z","timestamp":1649747000000},"page":"764-776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1403-1882","authenticated-orcid":false,"given":"Yu","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqiu","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"859_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/jcm6020016","volume":"6","author":"A Zufferey","year":"2017","unstructured":"Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017;6:16.","journal-title":"J Clin Med."},{"key":"859_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MOH.0000000000000612","volume":"27","author":"JW Semple","year":"2020","unstructured":"Semple JW, Rebetz J, Maouia A, Kapur R. An update on the pathophysiology of immune thrombocytopenia. Curr Opin Hematol. 2020;27:423\u20139.","journal-title":"Curr Opin Hematol"},{"key":"859_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper N, Ghanima W. Immune thrombocytopenia. N. Engl J Med 2019;381:945\u201355.","journal-title":"N. Engl J Med"},{"key":"859_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1182\/blood-2013-08-523308","volume":"123","author":"L Guo","year":"2014","unstructured":"Guo L, Yang L, Speck ER, Aslam R, Kim M, McKenzie CGJ, et al. Allogeneic platelet transfusions prevent murine T-cell-mediated immune thrombocytopenia. Blood. 2014;123:422\u20137.","journal-title":"Blood"},{"key":"859_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2015-06-655126","volume":"127","author":"L Guo","year":"2016","unstructured":"Guo L, Kapur R, Aslam R, Speck ER, Zufferey A, Zhao Y, et al. CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia. Blood. 2016;127:735\u20138.","journal-title":"Blood"},{"key":"859_CR6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","volume":"16","author":"S Audia","year":"2017","unstructured":"Audia S, Mah\u00e9vas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev 2017;16:620\u201332.","journal-title":"Autoimmun Rev"},{"key":"859_CR7","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/nm921","volume":"9","author":"B Olsson","year":"2003","unstructured":"Olsson B, Andersson PO, Jernas M, Jacobsson S, Carlsson B, Carlsson LMS, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 2003;9:1123\u20134.","journal-title":"Nat Med"},{"key":"859_CR8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1182\/blood-2009-09-244772","volume":"115","author":"L Chow","year":"2010","unstructured":"Chow L, Aslam R, Speck ER, Kim M, Cridland N, Webster ML, et al. A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy. Blood. 2010;115:1247\u201353.","journal-title":"Blood"},{"key":"859_CR9","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1111\/bjh.16334","volume":"188","author":"JR Vrbensky","year":"2020","unstructured":"Vrbensky JR, Arnold DM, Kelton JG, Smith JW, Jaffer AM, Larch\u00e9 M, et al. Increased cytotoxic potential of CD8(+) T cells in immune thrombocytopenia. Br J Haematol. 2020;188:e72\u2013e76.","journal-title":"Br J Haematol"},{"key":"859_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1182\/blood-2015-03-635417","volume":"126","author":"L Ma","year":"2015","unstructured":"Ma L, Simpson E, Li J, Xuan M, Xu M, Baker L, et al. CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia. Blood. 2015;126:247\u201356.","journal-title":"Blood"},{"key":"859_CR11","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1182\/blood-2012-02-413526","volume":"120","author":"R Aslam","year":"2012","unstructured":"Aslam R, Hu Y, Gebremeskel S, Segel GB, Speck ER, Guo L, et al. Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia. Blood. 2012;120:2127\u201332.","journal-title":"Blood"},{"key":"859_CR12","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1182\/blood-2018-05-847624","volume":"133","author":"H Zhao","year":"2019","unstructured":"Zhao H, Ma Y, Li D, Sun T, Li L, Li P, et al. Low-dose chidamide restores immune tolerance in ITP in mice and humans. Blood. 2019;133:730\u201342.","journal-title":"Blood"},{"key":"859_CR13","doi-asserted-by":"publisher","first-page":"104096","DOI":"10.1016\/j.cellimm.2020.104096","volume":"351","author":"M Kostic","year":"2020","unstructured":"Kostic M, Zivkovic N, Cvetanovic A, Marjanovi\u0107 G. CD4(+) T cell phenotypes in the pathogenesis of immune thrombocytopenia. Cell Immunol 2020;351:104096.","journal-title":"Cell Immunol"},{"key":"859_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","volume":"19","author":"F Veglia","year":"2018","unstructured":"Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nat Immunol 2018;19:108\u201319.","journal-title":"Nat Immunol"},{"key":"859_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10555-020-09947-x","volume":"40","author":"K Cole","year":"2021","unstructured":"Cole K, Pravoverov K, Talmadge JE. Role of myeloid-derived suppressor cells in metastasis. Cancer Metastasis Rev 2021;40:391\u2013411.","journal-title":"Cancer Metastasis Rev"},{"key":"859_CR16","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.3389\/fimmu.2019.03070","volume":"10","author":"C Siret","year":"2019","unstructured":"Siret C, Collignon A, Silvy F, Robert S, Cheyrol T, Andr\u00e9 P, et al. Deciphering the crosstalk between myeloid-derived suppressor cells and regulatory T cells in pancreatic ductal adenocarcinoma. Front Immunol 2019;10:3070.","journal-title":"Front Immunol"},{"key":"859_CR17","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1182\/blood-2015-10-674531","volume":"127","author":"Y Hou","year":"2016","unstructured":"Hou Y, Feng Q, Xu M, Li G, Liu X, Sheng Z, et al. High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia. Blood. 2016;127:1587\u201397.","journal-title":"Blood"},{"key":"859_CR18","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","volume":"129","author":"MP Lambert","year":"2017","unstructured":"Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood. 2017;129:2829\u201335.","journal-title":"Blood"},{"key":"859_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrm.2016.152","volume":"18","author":"ER Weikum","year":"2017","unstructured":"Weikum ER, Knuesel MT, Ortlund EA, Yamamoto KR. Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol 2017;18:159\u201374.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"859_CR20","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1101\/gr.248187.119","volume":"29","author":"SK Sasse","year":"2019","unstructured":"Sasse SK, Gruca M, Allen MA, Kadiyala V, Song T, Gally F, et al. Nascent transcript analysis of glucocorticoid crosstalk with TNF defines primary and cooperative inflammatory repression. Genome Res 2019;29:1753\u201365.","journal-title":"Genome Res"},{"key":"859_CR21","doi-asserted-by":"publisher","first-page":"R121","DOI":"10.1530\/JME-18-0152","volume":"62","author":"HE Lapp","year":"2019","unstructured":"Lapp HE, Bartlett AA, Hunter RG. Stress and glucocorticoid receptor regulation of mitochondrial gene expression. J Mol Endocrinol. 2019;62:R121\u2013r128.","journal-title":"J Mol Endocrinol"},{"key":"859_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0960-0760(95)00159-W","volume":"55","author":"C Demonacos","year":"1995","unstructured":"Demonacos C, Djordjevic-Markovic R, Tsawdaroglou N, Sekeris CE. The mitochondrion as a primary site of action of glucocorticoids: the interaction of the glucocorticoid receptor with mitochondrial DNA sequences showing partial similarity to the nuclear glucocorticoid responsive elements. J Steroid Biochem Mol Biol 1995;55:43\u201355.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"859_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.exger.2014.03.027","volume":"56","author":"TJ Nicholls","year":"2014","unstructured":"Nicholls TJ, Minczuk M. In D-loop: 40 years of mitochondrial 7S DNA. Exp Gerontol 2014;56:175\u201381.","journal-title":"Exp Gerontol"},{"key":"859_CR24","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.3390\/ijms20225643","volume":"20","author":"S DiMauro","year":"2019","unstructured":"DiMauro S. A brief history of mitochondrial pathologies. Int J Mol Sci. 2019;20:5643.","journal-title":"Int J Mol Sci."},{"key":"859_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/nbt.3997","volume":"35","author":"A Greenfield","year":"2017","unstructured":"Greenfield A, Braude P, Flinter F, Lovell-Badge R, Ogilvie C, Perry ACF. Assisted reproductive technologies to prevent human mitochondrial disease transmission. Nat Biotechnol 2017;35:1059\u201368.","journal-title":"Nat Biotechnol"},{"key":"859_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcell.2020.00004","volume":"8","author":"Z Dong","year":"2020","unstructured":"Dong Z, Pu L, Cui H. Mitoepigenetics and its emerging roles in cancer. Front Cell Dev Biol 2020;8:4.","journal-title":"Front Cell Dev Biol"},{"key":"859_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/bs.mcb.2019.11.007","volume":"155","author":"AE Frazier","year":"2020","unstructured":"Frazier AE, Vincent AE, Turnbull DM, Thorburn DR, Taylor RW. Assessment of mitochondrial respiratory chain enzymes in cells and tissues. Methods Cell Biol. 2020;155:121\u201356.","journal-title":"Methods Cell Biol"},{"key":"859_CR28","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2018.07.030","volume":"174","author":"MP Murphy","year":"2018","unstructured":"Murphy MP, O\u2019Neill LAJ. Krebs cycle reimagined: the emerging roles of succinate and itaconate as signal transducers. Cell. 2018;174:780\u20134.","journal-title":"Cell"},{"key":"859_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.stem.2020.06.005","volume":"27","author":"LTP Khoa","year":"2020","unstructured":"Khoa LTP, Tsan YC, Mao F, Kremer DM, Sajjakulnukit P, Zhang L, et al. Histone acetyltransferase MOF blocks acquisition of quiescence in ground-state ESCs through activating fatty acid oxidation. Cell Stem Cell. 2020;27:441\u2013458.e10.","journal-title":"Cell Stem Cell."},{"key":"859_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrrheum.2017.37","volume":"13","author":"T Gaber","year":"2017","unstructured":"Gaber T, Strehl C, Buttgereit F. Metabolic regulation of inflammation. Nat Rev Rheumatol 2017;13:267\u201379.","journal-title":"Nat Rev Rheumatol"},{"key":"859_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41590-019-0407-0","volume":"20","author":"G Caputa","year":"2019","unstructured":"Caputa G, Castoldi A, Pearce EJ. Metabolic adaptations of tissue-resident immune cells. Nat Immunol 2019;20:793\u2013801.","journal-title":"Nat Immunol"},{"key":"859_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4172\/2155-9899.1000371","volume":"6","author":"C He","year":"2015","unstructured":"He C, Carter AB. The metabolic prospective and redox regulation of macrophage polarization. J Clin Cell Immunol. 2015;6:371.","journal-title":"J Clin Cell Immunol."},{"key":"859_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000504344","volume":"12","author":"C Michaeloudes","year":"2020","unstructured":"Michaeloudes C, Bhavsar PK, Mumby S, Xu B, Hui CKM, Chung KF, et al. Role of metabolic reprogramming in pulmonary innate immunity and its impact on lung diseases. J Innate Immun 2020;12:31\u201346.","journal-title":"J Innate Immun"},{"key":"859_CR34","doi-asserted-by":"publisher","first-page":"1242454","DOI":"10.1126\/science.1242454","volume":"342","author":"EL Pearce","year":"2013","unstructured":"Pearce EL, Poffenberger MC, Chang CH, Jones RG. Fueling immunity: insights into metabolism and lymphocyte function. Science. 2013;342:1242454.","journal-title":"Science"},{"key":"859_CR35","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fimmu.2019.01399","volume":"10","author":"D Yan","year":"2019","unstructured":"Yan D, Adeshakin AO, Xu M, Afolabi LO, Zhang G, Chen YH, et al. Lipid metabolic pathways confer the immunosuppressive function of myeloid-derived suppressor cells in tumor. Front Immunol 2019;10:1399.","journal-title":"Front Immunol"},{"key":"859_CR36","doi-asserted-by":"publisher","first-page":"e1344804","DOI":"10.1080\/2162402X.2017.1344804","volume":"6","author":"AA Al-Khami","year":"2017","unstructured":"Al-Khami AA, Zheng L, Del Valle L, Hossain F, Wyczechowska D, Zabaleta J, et al. Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells. Oncoimmunology. 2017;6:e1344804.","journal-title":"Oncoimmunology"},{"key":"859_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1189\/jlb.4MR1116-476R","volume":"102","author":"A Sica","year":"2017","unstructured":"Sica A, Strauss L. Energy metabolism drives myeloid-derived suppressor cell differentiation and functions in pathology. J Leukoc Biol 2017;102:325\u201334.","journal-title":"J Leukoc Biol"},{"key":"859_CR38","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","volume":"3","author":"F Hossain","year":"2015","unstructured":"Hossain F, Al-Khami AA, Wyczechowska D, Hernandez C, Zheng L, Reiss K, et al. Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies. Cancer Immunol Res 2015;3:1236\u201347.","journal-title":"Cancer Immunol Res"},{"key":"859_CR39","doi-asserted-by":"publisher","first-page":"115118","DOI":"10.1016\/j.taap.2020.115118","volume":"401","author":"Y Yao","year":"2020","unstructured":"Yao Y, Yao Q, Xue J, Tian X, An Q, Cui L, et al. Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor. Toxicol Appl Pharmacol 2020;401:115118.","journal-title":"Toxicol Appl Pharmacol"},{"key":"859_CR40","doi-asserted-by":"publisher","first-page":"e5637","DOI":"10.1590\/1414-431x20165637","volume":"50","author":"J Zhou","year":"2017","unstructured":"Zhou J, Zhou Y, Wen J, Sun X, Zhang X. Circulating myeloid-derived suppressor cells predict disease activity and treatment response in patients with immune thrombocytopenia. Braz J Med Biol Res 2017;50:e5637.","journal-title":"Braz J Med Biol Res"},{"key":"859_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1424-8","volume":"16","author":"X Shao","year":"2018","unstructured":"Shao X, Wu B, Cheng L, Li F, Zhan Y, Liu C, et al. Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment. J Transl Med 2018;16:48.","journal-title":"J Transl Med"},{"key":"859_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162\u201374.","journal-title":"Nat Rev Immunol"},{"key":"859_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","volume":"120","author":"C Groth","year":"2019","unstructured":"Groth C, Hu X, Weber R, Fleming V, Altevogt P, Utikal J, et al. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. Br J Cancer 2019;120:16\u201325.","journal-title":"Br J Cancer"},{"key":"859_CR44","doi-asserted-by":"publisher","first-page":"e954829","DOI":"10.4161\/21624011.2014.954829","volume":"4","author":"O Draghiciu","year":"2015","unstructured":"Draghiciu O, Lubbers J, Nijman HW, Daemen T. Myeloid derived suppressor cells-an overview of combat strategies to increase immunotherapy efficacy. Oncoimmunology. 2015;4:e954829.","journal-title":"Oncoimmunology"},{"key":"859_CR45","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.humimm.2016.05.024","volume":"77","author":"P Boros","year":"2016","unstructured":"Boros P, Ochando J, Zeher M. Myeloid derived suppressor cells and autoimmunity. Hum Immunol 2016;77:631\u20136.","journal-title":"Hum Immunol"},{"key":"859_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.132","volume":"7","author":"Q Qu","year":"2016","unstructured":"Qu Q, Zeng F, Liu X, Wang QJ, Deng F. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death Dis 2016;7:e2226.","journal-title":"Cell Death Dis"},{"key":"859_CR47","doi-asserted-by":"publisher","first-page":"e0218186","DOI":"10.1371\/journal.pone.0218186","volume":"14","author":"H Wang","year":"2019","unstructured":"Wang H, Lu J, Dolezal J, Kulkarni S, Zhang W, Chen A, et al. Inhibition of hepatocellular carcinoma by metabolic normalization. PLoS One 2019;14:e0218186.","journal-title":"PLoS One"},{"key":"859_CR48","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-immunol-032713-120236","volume":"32","author":"K Ganeshan","year":"2014","unstructured":"Ganeshan K, Chawla A. Metabolic regulation of immune responses. Annu Rev Immunol 2014;32:609\u201334.","journal-title":"Annu Rev Immunol"},{"key":"859_CR49","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol 2016;16:553\u201365.","journal-title":"Nat Rev Immunol"},{"key":"859_CR50","first-page":"63","volume":"166","author":"MD Buck","year":"2016","unstructured":"Buck MD, O'Sullivan D, Klein Geltink RI, Curtis JD, Chang CH, Sanin DE, et al. Mitochondrial Dynamics Controls T. Cell Fate Metab Program Cell. 2016;166:63\u201376.","journal-title":"Cell Fate Metab Program Cell"},{"key":"859_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1471-y","volume":"11","author":"J Seok","year":"2020","unstructured":"Seok J, Jung HS, Park S, Lee JO, Kim CJ, Kim GJ. Alteration of fatty acid oxidation by increased CPT1A on replicative senescence of placenta-derived mesenchymal stem cells. Stem Cell Res Ther 2020;11:1.","journal-title":"Stem Cell Res Ther"},{"key":"859_CR52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cell.2017.08.018","volume":"171","author":"RI Klein Geltink","year":"2017","unstructured":"Klein Geltink RI, O'Sullivan D, Corrado M, Bremser A, Buck MD, Buescher JM, et al. Mitochondrial Priming by CD28. Cell. 2017;171:385\u201397.e11.","journal-title":"Cell"},{"key":"859_CR53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fcell.2020.00115","volume":"8","author":"M Cl\u00e9mot","year":"2020","unstructured":"Cl\u00e9mot M, S\u00eanos Demarco R, Jones DL. Lipid mediated regulation of adult stem cell behavior. Front Cell Dev Biol. 2020;8:115.","journal-title":"Front Cell Dev Biol"},{"key":"859_CR54","doi-asserted-by":"crossref","unstructured":"Pompura SL, Wagner A, Kitz A, LaPerche J, Yosef N, Dominguez-Villar M, et al. Oleic acid restores suppressive defects in tissue-resident FOXP3 Tregs from patients with multiple sclerosis. J Clin Invest. 2021;131:e138519.","DOI":"10.1172\/JCI138519"},{"key":"859_CR55","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/ni.3532","volume":"17","author":"MZ Cader","year":"2016","unstructured":"Cader MZ, Boroviak K, Zhang Q, Assadi G, Kempster SL, Sewell GW, et al. C13orf31 (FAMIN) is a central regulator of immunometabolic function. Nat Immunol 2016;17:1046\u201356.","journal-title":"Nat Immunol"},{"key":"859_CR56","doi-asserted-by":"publisher","first-page":"105334","DOI":"10.1016\/j.phrs.2020.105334","volume":"166","author":"M Yang","year":"2021","unstructured":"Yang M, Chen J, Wei W. Dimerization of glucocorticoid receptors and its role in inflammation and immune responses. Pharmacol Res 2021;166:105334.","journal-title":"Pharmacol Res"},{"key":"859_CR57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0092-8674(02)00817-6","volume":"110","author":"RK Bledsoe","year":"2002","unstructured":"Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell. 2002;110:93\u2013105.","journal-title":"Cell"},{"key":"859_CR58","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0092-8674(00)81183-6","volume":"93","author":"HM Reichardt","year":"1998","unstructured":"Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell. 1998;93:531\u201341.","journal-title":"Cell"},{"key":"859_CR59","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.3390\/ijms21186683","volume":"21","author":"A Kobayashi","year":"2020","unstructured":"Kobayashi A, Azuma K, Ikeda K, Inoue S. Mechanisms underlying the regulation of mitochondrial respiratory chain complexes by nuclear steroid receptors. Int J Mol Sci. 2020;21:6683.","journal-title":"Int J Mol Sci."},{"key":"859_CR60","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1073\/pnas.1602185113","volume":"113","author":"RG Hunter","year":"2016","unstructured":"Hunter RG, Seligsohn M, Rubin TG, Griffiths BB, Ozdemir Y, Pfaff DW, et al. Stress and corticosteroids regulate rat hippocampal mitochondrial DNA gene expression via the glucocorticoid receptor. Pnas USA. 2016;113:9099\u2013104.","journal-title":"Pnas USA"},{"key":"859_CR61","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/bjh.17205","volume":"192","author":"EL Williams","year":"2021","unstructured":"Williams EL, Stimpson ML, Lait P, Schewitz-Bowers LP, Jones LV, Dhanda AD, et al. Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14(++) CD16(+) intermediate monocytes from a pro-inflammatory to an anti-inflammatory phenotype. Br J Haematol 2021;192:375\u201384.","journal-title":"Br J Haematol"},{"key":"859_CR62","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/bjh.17204","volume":"192","author":"R Kapur","year":"2021","unstructured":"Kapur R. Monocytes as potential therapeutic sensors in glucocorticoid-treated newly diagnosed immune thrombocytopenia. Br J Haematol 2021;192:233\u20134.","journal-title":"Br J Haematol"},{"key":"859_CR63","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1210\/en.2008-0051","volume":"149","author":"R Arumugam","year":"2008","unstructured":"Arumugam R, Horowitz E, Lu D, Collier JJ, Ronnebaum S, Fleenor D, et al. The interplay of prolactin and the glucocorticoids in the regulation of beta-cell gene expression, fatty acid oxidation, and glucose-stimulated insulin secretion: implications for carbohydrate metabolism in pregnancy. Endocrinology. 2008;149:5401\u201314.","journal-title":"Endocrinology"},{"key":"859_CR64","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1182\/blood-2017-11-785865","volume":"131","author":"BR Blazar","year":"2018","unstructured":"Blazar BR, MacDonald KPA, Hill GR. Immune regulatory cell infusion for graft-versus-host disease prevention and therapy. Blood. 2018;131:2651\u201360.","journal-title":"Blood"},{"key":"859_CR65","doi-asserted-by":"crossref","unstructured":"Crow AR, Kapur R, Koernig S, Campbell IK, Jen C-C, Mott PJ, et al. Treating murine inflammatory diseases with an anti-erythrocyte antibody. Sci Transl Med. 2019;11:eaau8217.","DOI":"10.1126\/scitranslmed.aau8217"},{"key":"859_CR66","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.transproceed.2017.11.014","volume":"50","author":"T Nakao","year":"2018","unstructured":"Nakao T, Nakamura T, Masuda K, Matsuyama T, Ushigome H, Ashihara E, et al. Dexamethasone prolongs cardiac allograft survival in a murine model through myeloid-derived suppressor cells. Transplant Proc 2018;50:299\u2013304.","journal-title":"Transplant Proc"},{"key":"859_CR67","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/BF00416707","volume":"71","author":"H Radloff","year":"1971","unstructured":"Radloff H, Groher W. [Development and therapy of pseudarthroses of the humerus]. Arch Orthop Unfallchir. 1971;71:205\u201315.","journal-title":"Arch Orthop Unfallchir"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00859-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00859-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00859-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T23:06:47Z","timestamp":1743203207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00859-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":67,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1038\/s41423-022-00859-0","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]},"assertion":[{"value":"12 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}